» Articles » PMID: 32744314

Investigation of IL-4, IL-10, and HVEM Polymorphisms with Esophageal Squamous Cell Carcinoma: a Case-control Study Involving 1929 Participants

Overview
Journal Biosci Rep
Specialty Cell Biology
Date 2020 Aug 4
PMID 32744314
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

It is believed that an individual's hereditary factors may be involved in the development of esophageal cancer (EC). The present study recruited 721 esophageal squamous cell carcinoma (ESCC) cases and 1208 controls and explored the roles of single nucleotide polymorphisms (SNPs) in the interleukin-4 (IL-4), IL-10, and herpesvirus entry mediator (HVEM) genes in contributing to ESCC risk. IL-4, IL-10, and HVEM SNPs were analyzed by employing an SNPscan method. After adjustment for body mass index (BMI), smoking, drinking, age and gender, we identified that the rs2070874 T>C locus in IL-4 gene decreased the risk of ESCC (CC vs. TT: P=0.008; CC vs. TT/TC: P=0.010). After a stratified analysis, we suggested that the IL-4 rs2070874 T>C variants might be a protective factor for ESCC in male, ≥63 years old, never smoking, drinking and BMI < 24 kg/m2 subgroups. In addition, we identified that the rs2243263 G>C polymorphism in IL-4 gene was a risk factor for ESCC development in the BMI ≥ 24 kg/m2 subgroup (GC vs. GG: P=0.030 and GC/CC vs. GG: P=0.018). We identified an association of the IL-4 rs2070874 T>C SNP with the decreased susceptibility of ESCC in stage I/II subgroup. Finally, we found an association of the IL-10 rs1800872 T>G SNP with a worse differentiation (TG vs. TT: P=0.048 and GG/TG vs. TT: P=0.032). In conclusion, the findings indicate a potential importance of IL-4 rs2070874 T>C, IL-4 rs2243263 G>C and IL-10 rs1800872 T>G SNPs in the development of ESCC.

Citing Articles

Subtype cluster analysis unveiled the correlation between m6A- and cuproptosis-related lncRNAs and the prognosis, immune microenvironment, and treatment sensitivity of esophageal cancer.

Zhang M, Su Y, Wen P, Shao X, Yang P, An P Front Immunol. 2025; 16:1539630.

PMID: 40034693 PMC: 11872909. DOI: 10.3389/fimmu.2025.1539630.


Mediating role of circulating inflammatory proteins in the effect of immune cells on esophageal cancer risk: A Mendelian randomization study.

Guo J, Si G, Song X, Si F Medicine (Baltimore). 2024; 103(44):e40374.

PMID: 39496002 PMC: 11537666. DOI: 10.1097/MD.0000000000040374.


Effect of Variations on the Clear Cell Renal Carcinoma Risk and Overall Survival.

Andrzejczak A, Malkiewicz B, Tupikowski K, Ptaszkowski K, Szydelko T, Karabon L Int J Mol Sci. 2024; 25(13).

PMID: 38999968 PMC: 11241222. DOI: 10.3390/ijms25136860.


Association of leptin receptor polymorphisms with susceptibility of non-small cell lung cancer: Evidence from 2249 subjects.

Tang W, Wang J, Dai T, Qiu H, Liu C, Chen S Cancer Med. 2024; 13(8):e7178.

PMID: 38659416 PMC: 11043686. DOI: 10.1002/cam4.7178.


Overview of Risk Factors for Esophageal Squamous Cell Carcinoma in China.

Conway E, Wu H, Tian L Cancers (Basel). 2023; 15(23).

PMID: 38067307 PMC: 10705141. DOI: 10.3390/cancers15235604.


References
1.
Nelms K, Keegan A, Zamorano J, Ryan J, Paul W . The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999; 17:701-38. DOI: 10.1146/annurev.immunol.17.1.701. View

2.
Sun T, Zhou Y, Yang M, Hu Z, Tan W, Han X . Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res. 2008; 68(17):7025-34. DOI: 10.1158/0008-5472.CAN-08-0806. View

3.
Zhao X, Lu C, Chu W, Zhang Y, Zhang B, Zeng Q . microRNA-214 Governs Lung Cancer Growth and Metastasis by Targeting Carboxypeptidase-D. DNA Cell Biol. 2016; 35(11):715-721. DOI: 10.1089/dna.2016.3398. View

4.
Kwasniak K, Czarnik-Kwasniak J, Maziarz A, Aebisher D, Zielinska K, Karczmarek-Borowska B . Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor β on cancer cells. Cent Eur J Immunol. 2019; 44(2):190-200. PMC: 6745546. DOI: 10.5114/ceji.2018.76273. View

5.
Liu D, Wang Y, Dong M, Guan S, Wang Y, Sun H . Polymorphisms in cytokine genes as prognostic markers in diffuse large B cell lymphoma patients treated with (R)-CHOP. Ann Hematol. 2016; 96(2):227-235. DOI: 10.1007/s00277-016-2857-x. View